It has been established that increased plasma levels of cytokines and chemokines, IL-6 in particular, are significantly higher in severe than in mild to moderate disease allowing to predict COVID-19 severity and survival (140–142) and correlate with the harshness of the disease. The gene discussed is IL6; the disease is COVID-19.